Table of Content

1 Pharmaceutical Cannabis Market Overview
1.1 Product Overview and Scope of Pharmaceutical Cannabis
1.2 Pharmaceutical Cannabis Segment by Type
1.2.1 Global Pharmaceutical Cannabis Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 THC-dominant
1.2.3 CBD-dominant
1.2.4 Balanced THC & CBD
1.3 Pharmaceutical Cannabis Segment by Application
1.3.1 Global Pharmaceutical Cannabis Sales Comparison by Application: (2021-2027)
1.3.2 Cancer
1.3.3 Arthritis
1.3.4 Migraine
1.3.5 Epilepsy
1.3.6 Others
1.4 Global Pharmaceutical Cannabis Market Size Estimates and Forecasts
1.4.1 Global Pharmaceutical Cannabis Revenue 2016-2027
1.4.2 Global Pharmaceutical Cannabis Sales 2016-2027
1.4.3 Pharmaceutical Cannabis Market Size by Region: 2016 Versus 2021 Versus 2027

2 Pharmaceutical Cannabis Market Competition by Manufacturers
2.1 Global Pharmaceutical Cannabis Sales Market Share by Manufacturers (2016-2021)
2.2 Global Pharmaceutical Cannabis Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Pharmaceutical Cannabis Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Pharmaceutical Cannabis Manufacturing Sites, Area Served, Product Type
2.5 Pharmaceutical Cannabis Market Competitive Situation and Trends
2.5.1 Pharmaceutical Cannabis Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pharmaceutical Cannabis Players Market Share by Revenue
2.5.3 Global Pharmaceutical Cannabis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Pharmaceutical Cannabis Retrospective Market Scenario by Region
3.1 Global Pharmaceutical Cannabis Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Pharmaceutical Cannabis Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Pharmaceutical Cannabis Market Facts & Figures by Country
3.3.1 North America Pharmaceutical Cannabis Sales by Country
3.3.2 North America Pharmaceutical Cannabis Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Pharmaceutical Cannabis Market Facts & Figures by Country
3.4.1 Europe Pharmaceutical Cannabis Sales by Country
3.4.2 Europe Pharmaceutical Cannabis Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pharmaceutical Cannabis Market Facts & Figures by Region
3.5.1 Asia Pacific Pharmaceutical Cannabis Sales by Region
3.5.2 Asia Pacific Pharmaceutical Cannabis Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Pharmaceutical Cannabis Market Facts & Figures by Country
3.6.1 Latin America Pharmaceutical Cannabis Sales by Country
3.6.2 Latin America Pharmaceutical Cannabis Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Pharmaceutical Cannabis Market Facts & Figures by Country
3.7.1 Middle East and Africa Pharmaceutical Cannabis Sales by Country
3.7.2 Middle East and Africa Pharmaceutical Cannabis Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Pharmaceutical Cannabis Historic Market Analysis by Type
4.1 Global Pharmaceutical Cannabis Sales Market Share by Type (2016-2021)
4.2 Global Pharmaceutical Cannabis Revenue Market Share by Type (2016-2021)
4.3 Global Pharmaceutical Cannabis Price by Type (2016-2021)

5 Global Pharmaceutical Cannabis Historic Market Analysis by Application
5.1 Global Pharmaceutical Cannabis Sales Market Share by Application (2016-2021)
5.2 Global Pharmaceutical Cannabis Revenue Market Share by Application (2016-2021)
5.3 Global Pharmaceutical Cannabis Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Canopy Growth Corporation
6.1.1 Canopy Growth Corporation Corporation Information
6.1.2 Canopy Growth Corporation Description and Business Overview
6.1.3 Canopy Growth Corporation Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Canopy Growth Corporation Pharmaceutical Cannabis Product Portfolio
6.1.5 Canopy Growth Corporation Recent Developments/Updates
6.2 GW Pharmaceuticals, plc
6.2.1 GW Pharmaceuticals, plc Corporation Information
6.2.2 GW Pharmaceuticals, plc Description and Business Overview
6.2.3 GW Pharmaceuticals, plc Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GW Pharmaceuticals, plc Pharmaceutical Cannabis Product Portfolio
6.2.5 GW Pharmaceuticals, plc Recent Developments/Updates
6.3 Aurora Cannabis, Inc.
6.3.1 Aurora Cannabis, Inc. Corporation Information
6.3.2 Aurora Cannabis, Inc. Description and Business Overview
6.3.3 Aurora Cannabis, Inc. Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Aurora Cannabis, Inc. Pharmaceutical Cannabis Product Portfolio
6.3.5 Aurora Cannabis, Inc. Recent Developments/Updates
6.4 Aphria, Inc.
6.4.1 Aphria, Inc. Corporation Information
6.4.2 Aphria, Inc. Description and Business Overview
6.4.3 Aphria, Inc. Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Aphria, Inc. Pharmaceutical Cannabis Product Portfolio
6.4.5 Aphria, Inc. Recent Developments/Updates
6.5 MedReleaf Corporation
6.5.1 MedReleaf Corporation Corporation Information
6.5.2 MedReleaf Corporation Description and Business Overview
6.5.3 MedReleaf Corporation Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2016-2021)
6.5.4 MedReleaf Corporation Pharmaceutical Cannabis Product Portfolio
6.5.5 MedReleaf Corporation Recent Developments/Updates
6.6 Insys Therapeutics, Inc.
6.6.1 Insys Therapeutics, Inc. Corporation Information
6.6.2 Insys Therapeutics, Inc. Description and Business Overview
6.6.3 Insys Therapeutics, Inc. Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Insys Therapeutics, Inc. Pharmaceutical Cannabis Product Portfolio
6.6.5 Insys Therapeutics, Inc. Recent Developments/Updates
6.7 CanniMed Therapeutics, Inc.
6.6.1 CanniMed Therapeutics, Inc. Corporation Information
6.6.2 CanniMed Therapeutics, Inc. Description and Business Overview
6.6.3 CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2016-2021)
6.4.4 CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Product Portfolio
6.7.5 CanniMed Therapeutics, Inc. Recent Developments/Updates
6.8 Cara Therapeutics, Inc.
6.8.1 Cara Therapeutics, Inc. Corporation Information
6.8.2 Cara Therapeutics, Inc. Description and Business Overview
6.8.3 Cara Therapeutics, Inc. Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Cara Therapeutics, Inc. Pharmaceutical Cannabis Product Portfolio
6.8.5 Cara Therapeutics, Inc. Recent Developments/Updates
6.9 United Cannabis Corporation
6.9.1 United Cannabis Corporation Corporation Information
6.9.2 United Cannabis Corporation Description and Business Overview
6.9.3 United Cannabis Corporation Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2016-2021)
6.9.4 United Cannabis Corporation Pharmaceutical Cannabis Product Portfolio
6.9.5 United Cannabis Corporation Recent Developments/Updates

7 Pharmaceutical Cannabis Manufacturing Cost Analysis
7.1 Pharmaceutical Cannabis Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pharmaceutical Cannabis
7.4 Pharmaceutical Cannabis Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pharmaceutical Cannabis Distributors List
8.3 Pharmaceutical Cannabis Customers

9 Pharmaceutical Cannabis Market Dynamics
9.1 Pharmaceutical Cannabis Industry Trends
9.2 Pharmaceutical Cannabis Growth Drivers
9.3 Pharmaceutical Cannabis Market Challenges
9.4 Pharmaceutical Cannabis Market Restraints

10 Global Market Forecast
10.1 Pharmaceutical Cannabis Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pharmaceutical Cannabis by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Pharmaceutical Cannabis by Type (2022-2027)
10.2 Pharmaceutical Cannabis Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pharmaceutical Cannabis by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Pharmaceutical Cannabis by Application (2022-2027)
10.3 Pharmaceutical Cannabis Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pharmaceutical Cannabis by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Pharmaceutical Cannabis by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Pharmaceutical Cannabis Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Pharmaceutical Cannabis Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Pharmaceutical Cannabis Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Pharmaceutical Cannabis Covered in This Study
Table 5. Global Pharmaceutical Cannabis Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Pharmaceutical Cannabis Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Pharmaceutical Cannabis Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Pharmaceutical Cannabis Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Pharmaceutical Cannabis Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Pharmaceutical Cannabis Manufacturing Sites and Area Served
Table 11. Manufacturers Pharmaceutical Cannabis Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Pharmaceutical Cannabis by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Cannabis as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Pharmaceutical Cannabis Sales by Region (2016-2021) & (K Units)
Table 16. Global Pharmaceutical Cannabis Sales Market Share by Region (2016-2021)
Table 17. Global Pharmaceutical Cannabis Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Pharmaceutical Cannabis Sales by Country (2016-2021) & (K Units)
Table 19. North America Pharmaceutical Cannabis Sales Market Share by Country (2016-2021)
Table 20. North America Pharmaceutical Cannabis Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Pharmaceutical Cannabis Revenue Market Share by Country (2016-2021)
Table 22. Europe Pharmaceutical Cannabis Sales by Country (2016-2021) & (K Units)
Table 23. Europe Pharmaceutical Cannabis Sales Market Share by Country (2016-2021)
Table 24. Europe Pharmaceutical Cannabis Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Pharmaceutical Cannabis Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Pharmaceutical Cannabis Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Pharmaceutical Cannabis Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Pharmaceutical Cannabis Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Pharmaceutical Cannabis Revenue Market Share by Region (2016-2021)
Table 30. Latin America Pharmaceutical Cannabis Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Pharmaceutical Cannabis Sales Market Share by Country (2016-2021)
Table 32. Latin America Pharmaceutical Cannabis Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Pharmaceutical Cannabis Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Pharmaceutical Cannabis Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Pharmaceutical Cannabis Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Pharmaceutical Cannabis Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Pharmaceutical Cannabis Revenue Market Share by Country (2016-2021)
Table 38. Global Pharmaceutical Cannabis Sales (K Units) by Type (2016-2021)
Table 39. Global Pharmaceutical Cannabis Sales Market Share by Type (2016-2021)
Table 40. Global Pharmaceutical Cannabis Revenue (Million US$) by Type (2016-2021)
Table 41. Global Pharmaceutical Cannabis Revenue Share by Type (2016-2021)
Table 42. Global Pharmaceutical Cannabis Price (US$/Unit) by Type (2016-2021)
Table 43. Global Pharmaceutical Cannabis Sales (K Units) by Application (2016-2021)
Table 44. Global Pharmaceutical Cannabis Sales Market Share by Application (2016-2021)
Table 45. Global Pharmaceutical Cannabis Revenue (Million US$) by Application (2016-2021)
Table 46. Global Pharmaceutical Cannabis Revenue Share by Application (2016-2021)
Table 47. Global Pharmaceutical Cannabis Price (US$/Unit) by Application (2016-2021)
Table 48. Canopy Growth Corporation Corporation Information
Table 49. Canopy Growth Corporation Description and Business Overview
Table 50. Canopy Growth Corporation Pharmaceutical Cannabis Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Canopy Growth Corporation Pharmaceutical Cannabis Product
Table 52. Canopy Growth Corporation Recent Developments/Updates
Table 53. GW Pharmaceuticals, plc Corporation Information
Table 54. GW Pharmaceuticals, plc Description and Business Overview
Table 55. GW Pharmaceuticals, plc Pharmaceutical Cannabis Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. GW Pharmaceuticals, plc Pharmaceutical Cannabis Product
Table 57. GW Pharmaceuticals, plc Recent Developments/Updates
Table 58. Aurora Cannabis, Inc. Corporation Information
Table 59. Aurora Cannabis, Inc. Description and Business Overview
Table 60. Aurora Cannabis, Inc. Pharmaceutical Cannabis Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Aurora Cannabis, Inc. Pharmaceutical Cannabis Product
Table 62. Aurora Cannabis, Inc. Recent Developments/Updates
Table 63. Aphria, Inc. Corporation Information
Table 64. Aphria, Inc. Description and Business Overview
Table 65. Aphria, Inc. Pharmaceutical Cannabis Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Aphria, Inc. Pharmaceutical Cannabis Product
Table 67. Aphria, Inc. Recent Developments/Updates
Table 68. MedReleaf Corporation Corporation Information
Table 69. MedReleaf Corporation Description and Business Overview
Table 70. MedReleaf Corporation Pharmaceutical Cannabis Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. MedReleaf Corporation Pharmaceutical Cannabis Product
Table 72. MedReleaf Corporation Recent Developments/Updates
Table 73. Insys Therapeutics, Inc. Corporation Information
Table 74. Insys Therapeutics, Inc. Description and Business Overview
Table 75. Insys Therapeutics, Inc. Pharmaceutical Cannabis Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Insys Therapeutics, Inc. Pharmaceutical Cannabis Product
Table 77. Insys Therapeutics, Inc. Recent Developments/Updates
Table 78. CanniMed Therapeutics, Inc. Corporation Information
Table 79. CanniMed Therapeutics, Inc. Description and Business Overview
Table 80. CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Product
Table 82. CanniMed Therapeutics, Inc. Recent Developments/Updates
Table 83. Cara Therapeutics, Inc. Corporation Information
Table 84. Cara Therapeutics, Inc. Description and Business Overview
Table 85. Cara Therapeutics, Inc. Pharmaceutical Cannabis Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Cara Therapeutics, Inc. Pharmaceutical Cannabis Product
Table 87. Cara Therapeutics, Inc. Recent Developments/Updates
Table 88. United Cannabis Corporation Corporation Information
Table 89. United Cannabis Corporation Description and Business Overview
Table 90. United Cannabis Corporation Pharmaceutical Cannabis Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. United Cannabis Corporation Pharmaceutical Cannabis Product
Table 92. United Cannabis Corporation Recent Developments/Updates
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Pharmaceutical Cannabis Distributors List
Table 96. Pharmaceutical Cannabis Customers List
Table 97. Pharmaceutical Cannabis Market Trends
Table 98. Pharmaceutical Cannabis Growth Drivers
Table 99. Pharmaceutical Cannabis Market Challenges
Table 100. Pharmaceutical Cannabis Market Restraints
Table 101. Global Pharmaceutical Cannabis Sales Forecast by Type (2022-2027) & (K Units)
Table 102. Global Pharmaceutical Cannabis Sales Market Share Forecast by Type (2022-2027)
Table 103. Global Pharmaceutical Cannabis Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 104. Global Pharmaceutical Cannabis Revenue Market Share Forecast by Type (2022-2027)
Table 105. Global Pharmaceutical Cannabis Sales Forecast by Application (2022-2027) & (K Units)
Table 106. Global Pharmaceutical Cannabis Sales Market Share Forecast by Application (2022-2027)
Table 107. Global Pharmaceutical Cannabis Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 108. Global Pharmaceutical Cannabis Revenue Market Share Forecast by Application (2022-2027)
Table 109. Global Pharmaceutical Cannabis Sales Forecast by Region (2022-2027) & (K Units)
Table 110. Global Pharmaceutical Cannabis Sales Market Share Forecast by Region (2022-2027)
Table 111. Global Pharmaceutical Cannabis Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 112. Global Pharmaceutical Cannabis Revenue Market Share Forecast by Region (2022-2027)
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pharmaceutical Cannabis
Figure 2. Global Pharmaceutical Cannabis Market Share by Type in 2020 & 2027
Figure 3. THC-dominant Product Picture
Figure 4. CBD-dominant Product Picture
Figure 5. Balanced THC & CBD Product Picture
Figure 6. Global Pharmaceutical Cannabis Market Share by Application in 2020 & 2027
Figure 7. Cancer
Figure 8. Arthritis
Figure 9. Migraine
Figure 10. Epilepsy
Figure 11. Others
Figure 12. Global Pharmaceutical Cannabis Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Pharmaceutical Cannabis Market Size 2016-2027 (US$ Million)
Figure 14. Global Pharmaceutical Cannabis Sales 2016-2027 (K Units)
Figure 15. Global Pharmaceutical Cannabis Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Pharmaceutical Cannabis Sales Share by Manufacturers in 2020
Figure 17. Global Pharmaceutical Cannabis Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Pharmaceutical Cannabis Players: Market Share by Revenue in 2020
Figure 19. Pharmaceutical Cannabis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Pharmaceutical Cannabis Sales Market Share by Region (2016-2021)
Figure 21. Global Pharmaceutical Cannabis Sales Market Share by Region in 2020
Figure 22. Global Pharmaceutical Cannabis Revenue Market Share by Region (2016-2021)
Figure 23. Global Pharmaceutical Cannabis Revenue Market Share by Region in 2020
Figure 24. U.S. Pharmaceutical Cannabis Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Pharmaceutical Cannabis Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Pharmaceutical Cannabis Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Pharmaceutical Cannabis Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Pharmaceutical Cannabis Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Pharmaceutical Cannabis Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Pharmaceutical Cannabis Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Pharmaceutical Cannabis Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Pharmaceutical Cannabis Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Pharmaceutical Cannabis Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Pharmaceutical Cannabis Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Pharmaceutical Cannabis Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Pharmaceutical Cannabis Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Pharmaceutical Cannabis Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Pharmaceutical Cannabis Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Pharmaceutical Cannabis Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Pharmaceutical Cannabis Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Pharmaceutical Cannabis Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Pharmaceutical Cannabis Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Pharmaceutical Cannabis Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Pharmaceutical Cannabis Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Pharmaceutical Cannabis Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Pharmaceutical Cannabis Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. UAE Pharmaceutical Cannabis Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Pharmaceutical Cannabis by Type (2016-2021)
Figure 49. Sales Market Share of Pharmaceutical Cannabis by Application (2016-2021)
Figure 50. Sales Market Share of Pharmaceutical Cannabis by Application in 2020
Figure 51. Revenue Share of Pharmaceutical Cannabis by Application (2016-2021)
Figure 52. Revenue Share of Pharmaceutical Cannabis by Application in 2020
Figure 53. Manufacturing Cost Structure of Pharmaceutical Cannabis
Figure 54. Manufacturing Process Analysis of Pharmaceutical Cannabis
Figure 55. Pharmaceutical Cannabis Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed